QR Code

Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study

Abstract Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is unclear. The aim of this study was to analyze prognostic factors for early...

Full description

Saved in:
Main Authors: Kamila Resova, Lukas Knybel, Tereza Parackova, Marian Rybar, Karel Cwiertka, Jakub Cvek
Format: Artigo
Language:Inglês
Published: BMC 2024-04-01
Series:Radiation Oncology
Subjects:
SBRT
ES-NSCLC
Overall survival
Online Access:https://doi.org/10.1186/s13014-024-02439-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items